Condition: Critical Illness · Sponsor: University of Manchester
The goal of this study is to investigate how the experiences of intensive care patients and their end-of-life wishes affect their willingness to accept intensive care treatment at different chances of survival. The main questions it aims to answer are: * What can ICU survivors' experiences of ICU treatment tell us about what it would be like to die whilst receiving ICU treatment? * How do ICU survivors' reflections about what it might be like to die on ICU relate to their own preferences for their end-of-life care? * What chance of survival would make ICU survivors willing to go through ICU treatment again, in light of the fact that the alternative chance is dying whilst experiencing ICU treatment? * How does the possibility of reduction in health-related quality of life and functional decline as a result of critical illness impact ICU survivors' willingness to accept ICU treatment again? Participating in this study will involve filling out a questionnaire and then taking part in an interview. Participants will be recruited through ICU review clinics and ICU steps groups. The study will last for two years and will be conducted at locations convenient to the participants or via zoom.
This description comes directly from the study's public registry record.
Thomas M Donaldson, MB/BChir · 07737298024 · thomas.donaldson-2@postgrad.manchester.ac.uk
Soren Holm · 0161 275 3588 · soren.holm@manchester.ac.uk
Always discuss trial participation with your own doctor first.
| University of Manchester | Manchester, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06027684